Multiple Myeloma – Sagar Lonial, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018

Wednesday December 12, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Sagar Lonial, MD, Professor and Chair, Hematology & Medical Oncology, Chief Medical Officer, Winship Cancer Institute of Emory University, discuss ALCYONE, GRIFFIN, and maintenance therapy (TOURMALINE-MM3), and other multiple myeloma clinical studies presented at the American Society of Hematology 2018 meeting

Featured Videos

Richard Finn, MD, outlines the role of TACE with systemic therapy in HCC

Melissa Johnson, MD, shares her thoughts on biomarker development in NSCLC

Melissa Johnson, MD, considers the recent data investigating atezolizumab in SCLC